Showing results (291-300 of 597) with videos related to
Sort By:
Pageof 60
Cancer Diagnosis & Prognosis|July 2, 2026
The Clinical Impact of Prognostic Nutritional Index at Recurrence of Pancreatic CancerTeruhisa Sakamoto, Kentaro Uehira, Jun Yoshida, et al.Cancer Diagnosis & Prognosis|July 2, 2026
Pediatric Distal Femoral Surface Tumor With Extraosseous Lesion Mimicking Parosteal Osteosarcoma: A Diagnostic ChallengeRio Wikanjaya, Sei Morinaga, Katsuhiro Hayashi, et al.Cancer Diagnosis & Prognosis|July 2, 2026
CDKN2A mRNA Over-expression Is Associated With CD8+ T Cell Exclusion and IDO1-Mediated Adaptive Immune Resistance in Gastric AdenocarcinomaSteven Lehrer, Peter RheinsteinCancer Diagnosis & Prognosis|July 2, 2026
Comparison of Automated Urinalysis Parameter Atyp.C and Urine Cytology for Detecting Bladder Carcinoma In SituRyu Shigehisa, Satoshi Fukata, Keisuke Sugimoto, et al.Cancer Diagnosis & Prognosis|July 2, 2026
Total Bone Uptake as a Quantitative Imaging Biomarker for Prostate Cancer With Bone MetastasesShunsuke Watanabe, Daisuke Motoyama, Kyohei Watanabe, et al.Cancer Diagnosis & Prognosis|May 4, 2026
Combined Soft and Hard Tissue Facial Lesions In Early Childhood Pioneering the Diagnosis of the Tumor Predisposition Syndrome Neurofibromatosis Type 1Reinhard E Friedrich, Felix K Kohlrusch, Christian Hagel, et al.Cancer Diagnosis & Prognosis|September 2, 2026
Immune Checkpoint Inhibitor Resistance in Rectal Adenocarcinoma Containing a Mismatch Repair Deficiency Component: A Case ReportKohei Okura, Haruka Takenaka, Hiroshi Fujita, et al.Cancer Diagnosis & Prognosis|September 2, 2026
Casein Kinase 1 Alpha 1 Is Over-expressed in Pancreatic Adenocarcinoma Tissues and Correlates With Shorter Patient SurvivalShin-Nosuke Yamashita, Yoshiatsu Tanaka, Shajedul Islam, et al.Cancer Diagnosis & Prognosis|September 2, 2026
Prognostic Impact of Recurrence Location in Locally Recurrent Rectal Cancer: A Single-Center Retrospective StudySho Nambara, Koji Ando, Tetsuro Kawazoe, et al.Cancer Diagnosis & Prognosis|May 11, 2023
Long-term Progression-free Survival With Pemetrexed Plus Bevacizumab in NSCLC PatientsShigen Hayashi, Kunihiko Miyazaki, Toshihiro Shiozawa, et al.Pageof 60